Cargando…
Low Seroprevalence of SARS-CoV-2 Antibodies during Systematic Antibody Screening and Serum Responses in Patients after COVID-19 in a German Transplant Center
The coronavirus disease 2019 (COVID-19) pandemic caused by SARS-CoV-2 denotes a global health issue. Data regarding COVID-19 incidence in kidney transplant recipients (KTR) are sparse. From 19 March to 19 May 2020, we performed a systematic screening for COVID-19 in KTR. Tests included serum analysi...
Autores principales: | Choi, Mira, Bachmann, Friederike, Naik, Marcel Ganesh, Duettmann, Wiebke, Duerr, Michael, Zukunft, Bianca, Schwarz, Tatjana, Corman, Victor Max, Liefeldt, Lutz, Budde, Klemens, Halleck, Fabian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690804/ https://www.ncbi.nlm.nih.gov/pubmed/33114149 http://dx.doi.org/10.3390/jcm9113401 |
Ejemplares similares
-
COVID-19 Outcomes in Kidney Transplant Recipients in a German Transplant Center
por: Mikhailov, Michael, et al.
Publicado: (2023) -
Initial Experience With SARS-CoV-2-Neutralizing Monoclonal Antibodies in Kidney or Combined Kidney-Pancreas Transplant Recipients
por: Bachmann, Friederike, et al.
Publicado: (2022) -
A single centre in-depth analysis of death with a functioning kidney graft and reasons for overall graft failure
por: Mayrdorfer, Manuel, et al.
Publicado: (2022) -
Poor Long-Term Renal Allograft Survival in Patients with Chronic Antibody-Mediated Rejection, Irrespective of Treatment—A Single Center Retrospective Study
por: Wu, Kaiyin, et al.
Publicado: (2021) -
Pan-Genotype Pre-Exposure Prophylaxis (PrEP) Allows Transplantation of HCV-Positive Donor Kidneys to Negative Transplant Recipients
por: Duerr, Michael, et al.
Publicado: (2020)